PSYC Completes and Publishes 2020 Audited Financials
March 22 2022 - 08:30AM
InvestorsHub NewsWire
PSYC Completes and
Publishes 2020 Audited
Financials
LAKE OSWEGO,OR -- March 22, 2022
-- InvestorsHub NewsWire -- PSYC Corporation (OTCPink:
PSYC) (“PSYC” or the “Company”) a media leader for the
emerging medicinal psychedelics sector, and authorities
behind Psychedelic
Spotlight, a top ranking
psychedelic news and information platform, is pleased to announce
they successfully completed the audit of their 2020 financials and
have made them available to the public on OTC markets. The full
document can be viewed here:
PSYC
2020 Amended & Audited
Financials
“We are incredibly pleased to
complete our 2020 audited financials and believe it represents
another very important milestone in our ongoing efforts to develop
the level of credibility and transparency for PSYC that we
recognize as essential to the long-term value we are building for
our shareholders,” said PSYC CEO, David Flores. “Credibility and
legitimacy are, in my opinion, elements that a company must earn
for themselves, and our focus remains on taking the steps necessary
to strengthen that credibility and legitimacy. This includes
working steadily and meticulously through a process that is
targeted on establishing a reliable revenue source, diversifying
our assets, and positioning ourselves to up list off the pink
sheets in the most effective and practical time frame possible. We
firmly believe that the successful completion of our 2020 audit
will help us move into the next phase of this ongoing
process.”
PSYC Advisor and Acting VP of
Finance added: “PSYC’s audited 2020 Financials are another
milestone en route to bigger and better things for the Company. The
process is neither easy nor fast, but it puts us on a fast track to
tackling our 2021 audit. We are now one step closer to our
overarching goals of being a fully current SEC reporting company,
up listing to the OTCQB, attracting more public market visibility,
increasing our ability to raise capital, and ultimately returning
value to our loyal shareholders and communities we
serve.”
About PSYC Corporation (OTCPink:
PSYC)
At PSYC Corporation we are
integrating media, creativity, and technology to develop and deploy
thought-provoking ideas and solutions that are fostering and
transforming the approach to some of society’s most pressing
matters.
PSYC has expressed its intent and
commitment to positioning itself at the forefront of the
psychedelic revolution and as a resource center for discovering and
understanding the latest research and business opportunities
surrounding psychedelic inspired medicines. In conjunction with the
FDA’s more open-minded approach to psychedelic medicines, and as
several major U.S. cities continue to approve the decriminalization
of psilocybin, we believe investors are speculating that the
psychedelic boom could be bigger than that of cannabis. PSYC is
your source for current investment related news specific to
psychedelic medicines and cutting-edge research improving overall
health, moving this sector into the mainstream.
We are dedicated to a
forward-thinking approach that embraces groundbreaking new
technology and innovations and through the vision of business
development we intend to continue to evolve into these unchartered
territories as the industry leaders of the
future.
Forward-Looking Statements
Disclaimer:
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. In some cases, you can
identify forward-looking statements by the following words:
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "ongoing," "plan," "potential," "predict,"
"project," "should," "will," "would," or the negative of these
terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results and
will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainty and other factors, including the effect of
COVID-19 and the success of the current vaccine distribution, the
adverse effect of the Omicron variant, that may cause our results,
levels of activity, performance or achievements to be materially
different from the information expressed or implied by the
forward-looking statements in this press release. This press
release should be considered in light of all filings of the Company
that are disclosed on the OTC Markets.com website and is not
incorporated by reference into such reports.
Disclaimer: PSYC Corporation
does not in any way encourage or condone the use, purchase, sale or
transfer of any illegal substances, nor do we encourage or condone
partaking in any unlawful activities. We support a harm reduction
approach for the purpose of education and promoting individual and
public safety. If you are choosing to use psychedelic substances,
please do so responsibly.
Corporate
Contact:
PSYC Corporation (PSYC)
www.psyccorporation.com
(702) 239-1919
info@psyccorporation.com
OTCPINK: PSYC
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Feb 2024 to Mar 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Mar 2023 to Mar 2024